Oral mucositis associated with anti-egfr therapy in colorectal cancer: single institutional retrospective cohort study.

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: DOTE, Satoshi (Kyoto-Katsura Hospital, Department of pharamcy, Kyoto, Japan)
  • Co-author(s): Satoshi Dote: Department of pharamcy, Kyoto-Katsura Hospital, Kyoto, Japan;Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
    Shoji Itakura: Department of pharamcy, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
    Daiki Hira: Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
    Satoshi Noda: Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
    Yuka Kobayashi: Department of pharamcy, Kyoto-Katsura Hospital, Kyoto, Japan
    Tomohiro Terada: Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
  • Abstract:

    Background

    The difference of severity of oral mucositis between anti-EGFR therapies combined with cytotoxics in colorectal cancer are not clear.

    Purpose

    The aim of this study was to investigate the differences of oral mucositis between panitumumab (Pmab) and cetuximab (Cmab) combined with 5FU.

    Methods

    We conducted a retrospective cohort study. A total ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login